UPDATE: Cantor Fitzgerald Assumes Arcturus Therapeutics (ARCT) at Overweight
Tweet Send to a Friend
(Updated - July 19, 2022 7:03 AM EDT)
Cantor Fitzgerald analyst Pete Stavropoulos assumes coverage on Arcturus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Pete Stavropoulos assumes coverage on Arcturus Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
